Luis R. Martinez Department of Microbiology and Immunology Albert Einstein College of Medicine Biography Publications Institution JoVE Articles Luis R. Martinez has not added a biography. If you are Luis R. Martinez and would like to personalize this page please email our Author Liaison for assistance. Publications Nitric Oxide-Releasing Nanoparticles Accelerate Wound Healing by Promoting Fibroblast Migration and Collagen Deposition The American Journal of Pathology. Feb, 2012 | Pubmed ID: 22306734 Effects of Microplusin, a Copper-chelating Antimicrobial Peptide, Against Cryptococcus Neoformans FEMS Microbiology Letters. Nov, 2011 | Pubmed ID: 22092765 Chronological Aging is Associated with Biophysical and Chemical Changes in the Capsule of Cryptococcus Neoformans Infection and Immunity. Dec, 2011 | Pubmed ID: 21968999 Improved Antimicrobial Efficacy with Nitric Oxide Releasing Nanoparticle Generated S-nitrosoglutathione Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. Nov, 2011 | Pubmed ID: 21946032 Susceptibility of Gram-positive and -negative Bacteria to Novel Nitric Oxide-releasing Nanoparticle Technology Virulence. May-Jun, 2011 | Pubmed ID: 21577055 Candida Parapsilosis Fat Storage-inducing Transmembrane (FIT) Protein 2 Regulates Lipid Droplet Formation and Impacts Virulence Microbes and Infection / Institut Pasteur. Jul, 2011 | Pubmed ID: 21396481 Mycobacteria Release Active Membrane Vesicles That Modulate Immune Responses in a TLR2-dependent Manner in Mice The Journal of Clinical Investigation. Apr, 2011 | Pubmed ID: 21364279 Novel Therapies for Treatment of Multi-drug Resistant Acinetobacter Baumannii Skin Infections Virulence. Mar-Apr, 2011 | Pubmed ID: 21321482 Fungal Biofilms: Relevance in the Setting of Human Disease Current Fungal Infection Reports. Dec, 2010 | Pubmed ID: 21660222 The Use of Nitric Oxide Releasing Nanoparticles As a Treatment Against Acinetobacter Baumannii in Wound Infections Virulence. Mar-Apr, 2010 | Pubmed ID: 21178416 Monoclonal Antibodies Against Peptidorhamnomannans of Scedosporium Apiospermum Enhance the Pathogenicity of the Fungus PLoS Neglected Tropical Diseases. 2010 | Pubmed ID: 20976055 Demonstration of Antibiofilm and Antifungal Efficacy of Chitosan Against Candidal Biofilms, Using an in Vivo Central Venous Catheter Model The Journal of Infectious Diseases. May, 2010 | Pubmed ID: 20331379 Augmented Production of Panton-Valentine Leukocidin Toxin in Methicillin-resistant and Methicillin-susceptible Staphylococcus Aureus is Associated with Worse Outcome in a Murine Skin Infection Model The Journal of Infectious Diseases. Jan, 2010 | Pubmed ID: 19929693 The Use of Chitosan to Damage Cryptococcus Neoformans Biofilms Biomaterials. Feb, 2010 | Pubmed ID: 19819009 Nitric Oxide Releasing Nanoparticles Are Therapeutic for Staphylococcus Aureus Abscesses in a Murine Model of Infection PloS One. 2009 | Pubmed ID: 19915659 Methamphetamine Enhances Histoplasmosis by Immunosuppression of the Host The Journal of Infectious Diseases. Jul, 2009 | Pubmed ID: 19473099 Antimicrobial and Healing Efficacy of Sustained Release Nitric Oxide Nanoparticles Against Staphylococcus Aureus Skin Infection The Journal of Investigative Dermatology. Oct, 2009 | Pubmed ID: 19387479 Characterization of Phenotypic Switching in Cryptococcus Neoformans Biofilms Mycopathologia. Oct, 2008 | Pubmed ID: 18568421 Voriconazole Inhibits Melanization in Cryptococcus Neoformans Antimicrobial Agents and Chemotherapy. Dec, 2007 | Pubmed ID: 17923488 Caspofungin Reduces the Incidence of Fungal Contamination in Cell Culture Mycopathologia. Dec, 2007 | Pubmed ID: 17899440 Cryptococcus Neoformans Biofilm Formation Depends on Surface Support and Carbon Source and Reduces Fungal Cell Susceptibility to Heat, Cold, and UV Light Applied and Environmental Microbiology. Jul, 2007 | Pubmed ID: 17513597 Cryptococcus Neoformans Cells in Biofilms Are Less Susceptible Than Planktonic Cells to Antimicrobial Molecules Produced by the Innate Immune System Infection and Immunity. Nov, 2006 | Pubmed ID: 17057089 Specific Antibody to Cryptococcus Neoformans Glucurunoxylomannan Antagonizes Antifungal Drug Action Against Cryptococcal Biofilms in Vitro The Journal of Infectious Diseases. Jul, 2006 | Pubmed ID: 16779734 Susceptibility of Cryptococcus Neoformans Biofilms to Antifungal Agents in Vitro Antimicrobial Agents and Chemotherapy. Mar, 2006 | Pubmed ID: 16495265 Specific Antibody Can Prevent Fungal Biofilm Formation and This Effect Correlates with Protective Efficacy Infection and Immunity. Oct, 2005 | Pubmed ID: 16177306 Antibody to Cryptococcus Neoformans Glucuronoxylomannan Inhibits the Release of Capsular Antigen Infection and Immunity. Jun, 2004 | Pubmed ID: 15155683 Пассивный Администрации моноклональных антител против H. capsulatum И другие грибным патогенам Allan J. Guimarães1, Luis R. Martinez1, Joshua D. Nosanchuk1 1Department of Microbiology and Immunology, Albert Einstein College of Medicine JoVE 2532 Immunologie et Infection
Пассивный Администрации моноклональных антител против H. capsulatum И другие грибным патогенам Allan J. Guimarães1, Luis R. Martinez1, Joshua D. Nosanchuk1 1Department of Microbiology and Immunology, Albert Einstein College of Medicine JoVE 2532 Immunologie et Infection